Pharmaceutical Firm “Darnitsa” has been the leader in the sale of medicinal products by volume since 1998. The strategic directions of the product portfolio development of the company are cardiology, neurology and pain problems. Each 7 pack of medicines in pharmacy shelves is manufactured by Darnitsa.

The company’s net income from sales in 2018 grew by 18.7%, to UAH 3.002 billion. Over the past 10 years, the company has invested more than 200 million euros into technical development. 10% of gross profit is invested annually in development, in particular R&D. The Company’s portfolio includes nearly 250 names of finished medicinal products. The products of “Pharmaceutical Firm “Darnitsa” PrJSC are exported to 16 countries.

Please note!
Collaboration of companies with shared values is main goal of this project.
We will receive your message and, in two work days, we will redirect it to a company's employee whom it can be as useful as possible.
Your company has 10 opportunities per year to get acquainted with other companies. If you want to increase this amount, please contact us
Please note, that according to EBA Code of Conduct it is prohibited to perform on the EBA platform any coordinated actions, which may limit the competition between the EBA Members.
Write us in case of additional questions and suggestions.

Spelling error report

The following text will be sent to our editors: